@article{10500,
  keywords = {Anaphylactic reactions, Dipeptidyl peptidase-4 inhibitors, Glucagon-like peptide-1 receptor agonists, pharmacoepidemiology, Sodium-glucose cotransporter-2 inhibitors},
  author = {R. Pradhan and E. Patorno and H. Tesfaye and S. Schneeweiss and H. Yin and J. Franklin and A. Pawar and C. Santella and O. H. Y. Yu and C. Renoux and L. Azoulay},
  title = {Glucagon-Like Peptide-1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-Based Cohort Study},
  year = {2022},
  journal = {Am J Epidemiol},
  edition = {2022/02/10},
  isbn = {0002-9262},
  doi = {10.1093/aje/kwac021},
  note = {1476-6256
Pradhan, Richeek
Patorno, Elisabetta
Tesfaye, Helen
Schneeweiss, Sebastian
Yin, Hui
Franklin, Jessica
Pawar, Ajinkya
Santella, Christina
Yu, Oriana H Y
Renoux, Christel
Azoulay, Laurent
Journal Article
United States
Am J Epidemiol. 2022 Feb 5:kwac021. doi: 10.1093/aje/kwac021.},
  language = {eng},
}